| Drug Name: | Indoramin (26844-12-2) |
|---|---|
| PubChem ID: | 33625 |
| SMILES: | C1CN(CCC1NC(=O)C2=CC=CC=C2)CCC3=CNC4=CC=CC=C43 |
| InchiKey: | JXZZEXZZKAWDSP-UHFFFAOYSA-N |
| Therapeutic Category: | Adrenergic Agents, Adrenergic alpha-1 Receptor Antagonists, Adrenergic alpha-Antagonists, Adrenergic Antagonists, Antihypertensive Agents, Cardiovascular Agents, Neurotransmitter Agents |
| Molecular Weight (dalton) | : | 347.462 |
| LogP | : | 3.6048 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 48.13 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Bradycardia | MetaADEDB |
| Hypertension | MetaADEDB |
| Hypotension | MetaADEDB |